Fredrick is a bioinformatician with background in microbial and cancer genomics. Fredrick studied a Masters of Bioinformatics degree from Wageningen University in the Netherlands before obtaining a PhD from Radboud University, the Netherlands. During his PhD, Fredrick used whole-genome sequencing to characterise how pneumococcal genotypes relates with etiology and epidemiology of pneumococcal disease, as well as resistance to antimicrobial drugs. He also worked as a visiting researcher at the pathogen genomics group of the Wellcome Trust Sanger Institute in Cambridge where he studied the effects of mass vaccination with PCV7 on pneumococcal carriage and invasive disease. Prior to joining SAHMRI, Fredrick worked as a postdoctoral fellow at the Computational Cancer Biology group of the Netherlands Cancer Institute in Amsterdam, evaluating the molecular response of AML lines to lysine-specific demethylase 1 (LSD1) inhibition, and identifying the mechanisms and biomarkers of resistance as well as sensitivity to LSD1 inhibition. Fredrick's work at SAHMRI focuses on utilizing bioinformatics tools for metagenomic sequencing data analysis to characterize the human microbiome and analyse its role in health and disease.